Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 52-Week High – Here’s What Happened

Shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) hit a new 52-week high on Thursday . The stock traded as high as $11.28 and last traded at $10.94, with a volume of 27479 shares trading hands. The stock had previously closed at $10.76.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. KGaA in a research note on Monday, February 3rd.

Fresenius SE & Co. KGaA Trading Down 5.3 %

The firm has a market cap of $23.14 billion, a P/E ratio of 49.33 and a beta of 0.86. The business’s 50 day moving average is $10.28 and its 200-day moving average is $9.49. The company has a quick ratio of 1.05, a current ratio of 1.36 and a debt-to-equity ratio of 0.57.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last issued its earnings results on Wednesday, February 26th. The company reported $0.18 earnings per share (EPS) for the quarter. The company had revenue of $6.01 billion during the quarter. As a group, analysts forecast that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.